Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

CYTK Cytokinetics Inc

45,74

-1,25 (-2,66%)

18 Jan 2025 - Geschlossen

Verzögert um 15 Minuten

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Cytokinetics (NASDAQ:CYTK)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Cytokinetics Charts.

Cytokinetics (NASDAQ:CYTK)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Cytokinetics Charts.

News Cytokinetics Inc

Cytokinetics Announces 2025 Corporate Milestones and Vision 2030
Montag 13 Januar 2025 (1 Woche vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 10 Januar 2025 (1 Woche vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Dienstag 7 Januar 2025 (2 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 6 Januar 2025 (2 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 6 Januar 2025 (2 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 6 Januar 2025 (2 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 6 Januar 2025 (2 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 6 Januar 2025 (2 Wochen vor) • Edgar (US Regulatory)

Cytokinetics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Montag 6 Januar 2025 (2 Wochen vor) • GlobeNewswire Inc.

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Freitag 3 Januar 2025 (2 Wochen vor) • GlobeNewswire Inc.

Cytokinetics Announces European Medicines Agency Validation of Marketing Authorization Application for Aficamten for the Treatment of Obstructive Hypertrophic Cardiomyopathy
Montag 23 Dezember 2024 (4 Wochen vor) • GlobeNewswire Inc.

Cytokinetics Announces Sanofi Acquired Rights to Develop and Commercialize Aficamten in Greater China
Freitag 20 Dezember 2024 (1 Monat vor) • GlobeNewswire Inc.

Weitere Cytokinetics Inc News-Artikel

Health Care Select Sector

Deutsche Telekom

JP Morgan Chase

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen